USING CYCLOPAMINE IN TREATMENT OF BASAL CELL EPITHELIOMA (CARCINOMA) AND OTHER TUMORS Russian patent published in 2007 - IPC A61K31/4355 A61K31/34 A61P35/00 

FIELD: medicine, oncology, biology, pharmacy.

SUBSTANCE: the claimed invention involves using inhibitors. Invention relates to using cyclopamine and its pharmaceutically acceptable salts for preparing a pharmaceutical agent for induction of apoptosis of tumor cells that use transfer of Hedgehog/Smoothened signal for prophylaxis of apoptosis. Cyclopamine causes apoptosis by not genotoxic mechanism and therefore it distinguishes from radiation therapy and most of the modern anticancer chemotherapeutic agent that effect inducing DNA damages. These new effects early not achieved in cancer chemotherapy provide using cyclopamine as to be very desirable in cancer therapy, in treatment of BCC (basal cell carcinoma) and other tumors that use way of signal transduction of hedgehog/smoothened protein for proliferation and prophylaxis of apoptosis.

EFFECT: valuable medicinal properties of cyclopamine.

6 cl, 1 tbl, dwg 7